TENX Tenax Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Tem 31, 2026
$1,98
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,3152 haftanın en düşüğü
$19,4052 haftanın en yükseği
Piyasa Değeri (MRQ)
$63M
P/E (TTM)
-1.3
Hisse Başına Kâr (TTM)
$-1.49
Gelir (TTM)
$0
rozetleriniz
52 Haftlık Aralık
$1–$19
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$13
P/E
-1.3
ROE
-59.8%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
TENX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.98
Piyasa Değeri (MRQ)
$63M
P/E (TTM)
-1.3
Hisse Başına Kâr (TTM)
$-1.49
Gelir (TTM)
$0
ROE (TTM)
-59.8%
52 Haftlık Aralık
$1–$19
TENX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 03 Ocak 2024 | 1-for-80 | Ters |
| 05 Ocak 2023 | 1-for-20 | Ters |
| 26 Şubat 2018 | 1-for-20 | Ters |
| 13 Mayıs 2013 | 1-for-20 | Ters |
| 09 Kasım 2009 | 1-for-15 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$02016-12-31 → 2025-12-31
Hisse Başına Kâr$-1.342023-12-31 → 2025-12-31
Serbest Nakit Akışı·2016-12-31 → 2022-12-31
Net kar marjı·2021-12-31 → 2021-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | TENX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -1.35Y ort. ≈-487.7 | ≈-487.7 | · | · | |
| F/D (MRQ) | 0.65Y ort. ≈2031.3 | ≈2031.3 | 3.7 | Adil değer | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -0.55Y ort. ≈-780.6 | ≈-780.6 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 0.25Y ort. ≈2031.3 | ≈2031.3 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | TENX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA (TTM) | -57.0%5Y ort. ≈-144.6% | ≈-144.6% | -83.9% | En üst düzey | |
| ROE (TTM) | -59.8%5Y ort. ≈-192.6% | ≈-192.6% | -86.5% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | TENX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 15.15Y ort. ≈8.8 | ≈8.8 | 5.3 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 13.65Y ort. ≈9.6 | ≈9.6 | 4.7 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | TENX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.05Y ort. ≈0.0 | ≈0.0 | 0.0 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$0.00 | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-8.0%
Sonraki Rapor
Kas 10, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 11, 2026 | $-0.35 | $-0.37 | 5.1% |
| 31 Mart 2026 | May 12, 2026 | $-0.35 | $-0.41 | 14.2% |
| 31 Aralık 2025 | $-0.38 | $-0.42 | 10.2% | |
| 30 Eylül 2025 | $-0.40 | $-0.32 | -25.5% | |
| 30 Haziran 2025 | $-0.27 | $-0.24 | -10.3% | |
| 31 Mart 2025 | $-0.28 | $-0.20 | -42.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | · | · | · | · | · | · | · | $0 | · | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | $0 | · | |
| Gross Profit | · | · | · | · | · | · | · | · | · | $0 | · | |
| R&D Expense | $33M | $13M | $3M | $5M | $25M | $5M | $3M | $1M | $4M | $13M | · | |
| SG&A Expense | $24M | $7M | $5M | $6M | $8M | $5M | $5M | $6M | $6M | $6M | · | |
| Operating Expenses | $56M | $19M | $8M | $11M | $33M | $10M | $9M | $7M | $9M | $53M | · | |
| Operating Income | $-56M | $-19M | $-8M | $11M | $-33M | $10M | $-9M | $-7M | $-9M | $-53M | · | |
| Interest Expense | $0 | $23.0K | $24.0K | $4.4K | $949 | $1.6K | $0 | · | · | $0 | · | |
| Other Non-op | $-33.0K | $1.0K | $63.0K | $-9.2K | · | $18.2K | $160.9K | $79.8K | $366.2K | $764.7K | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-8M | $0 | |
| Net Income | $-53M | $-18M | $-8M | $11M | $-32M | $-10M | $-8M | $-14M | $-9M | $-44M | · | |
| EPS (Basic) | $-1.34 | $-1.15 | $-31.04 | · | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.34 | $-1.15 | $-31.04 | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 39,217,244 | 15,271,705 | 248,447 | · | · | · | · | · | · | · | · | |
| Shares (Diluted) | 39,217,244 | 15,271,705 | 248,447 | · | · | · | · | · | · | · | · | |
| EBITDA | $-56M | $-19M | $8M | $-11M | $33M | $-10M | $-9M | $-7M | $-9M | $-53M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $98M | $95M | $10M | $2M | $6M | $6M | $5M | $12M | $2M | $10M | $4M | |
| Short-term Investments | · | · | · | · | $0 | $462.7K | $493.9K | $494.6K | $6M | $3M | $17M | |
| Receivables | · | · | · | · | · | · | · | $0 | $50.2K | $72.6K | $49.4K | |
| Prepaid Expense | $6M | $2M | $2M | $738.9K | $105.1K | $82.6K | $781.0K | $458.3K | $285.5K | $275.0K | $322.0K | |
| Other Current Assets | $1M | $64.0K | $252.0K | $345.9K | $0 | · | · | · | · | · | · | |
| Current Assets | $104M | $97M | $12M | $3M | $6M | $7M | $6M | $13M | $8M | $14M | $21M | |
| PP&E (Net) | · | · | $0 | $7.2K | $7.1K | $6.0K | $6.6K | $8.5K | $9.9K | $19.1K | $35.8K | |
| PP&E (Gross) | · | · | · | · | · | $66.3K | $210.9K | $581.6K | $574.1K | $586.7K | $784.4K | |
| Accum. Depreciation | · | · | · | · | · | $60.4K | $204.3K | $573.1K | $564.1K | $567.6K | $748.6K | |
| Goodwill | · | · | · | · | · | · | · | · | · | $0 | $11M | |
| Intangibles | · | · | · | · | · | · | · | · | · | $0 | $22M | |
| Other Non-current Assets | · | $0 | $1.0K | $9.6K | $8.4K | $8.4K | $8.4K | $8.4K | $8.4K | $1M | $1M | |
| Total Assets | $104M | $97M | $12M | $3M | $6M | $7M | $6M | $13M | $10M | $23M | $73M | |
| Accounts Payable | $6M | $3M | $2M | $448.4K | $859.6K | $757.9K | $2M | $749.8K | $611.9K | $727.6K | $972.5K | |
| Accrued Liabilities | $1M | $2M | $1M | $775.0K | $704.3K | $1M | $871.3K | $815.9K | $363.3K | $5M | $3M | |
| Short-term Debt | · | $0 | $501.0K | $624.3K | $0 | $120.5K | $0 | · | · | · | · | |
| Current Liabilities | $7M | $5M | $4M | $2M | $2M | $2M | $3M | $2M | $1M | $6M | $5M | |
| Capital Leases | · | · | $0 | $64.2K | $183.6K | $0 | $60.4K | $0 | · | · | · | |
| Deferred Tax | · | · | · | · | · | $0 | · | · | · | · | · | |
| Total Liabilities | $7M | $5M | $4M | $2M | $2M | $2M | $3M | $2M | $1M | $6M | $13M | |
| Total Debt | · | $0 | $500.9K | $624.3K | $0 | $120.5K | · | · | · | · | · | |
| Common Stock | $1.0K | $0 | $0 | $3 | $2.5K | $0 | $674 | $379 | $141 | $2.8K | $2.8K | |
| Paid-in Capital | $465M | $407M | $305M | $291M | $283M | $251M | · | · | · | · | · | |
| Retained Earnings | $-367M | $-315M | $-297M | $-290M | $-278M | $-246M | $-236M | $-228M | $-213M | $-205M | $-161M | |
| AOCI | · | · | · | · | $0 | $-70 | $458 | $516 | $-16.2K | $-18.7K | $-129.4K | |
| Stockholders' Equity | $97M | $92M | $8M | $1M | $4M | $5M | $4M | $12M | $9M | $17M | $60M | |
| Liabilities + Equity | $104M | $97M | $12M | $3M | $6M | $7M | $6M | $13M | $10M | $23M | $73M | |
| Shares Outstanding | 9,314,130 | 3,420,906 | 298,281 | 28,648 | 1,260,346 | 12,619,369 | 6,741,860 | 3,792,249 | 1,411,840 | 1,406,002 | 28,119,694 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $0 | $8.0K | $5.1K | $4.1K | $4.1K | $5.0K | $9.0K | $13.6K | $19.0K | · | |
| Stock-based Comp | $19M | $1M | $191.0K | · | · | · | $0 | $190.1K | $79.6K | $1.1K | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | $0 | · | |
| Operating Cash Flow | $-36M | $-15M | $-6M | $-11M | $-11M | $-9M | $-8M | $-5M | $-12M | $-16M | · | |
| CapEx | · | · | · | $2.3K | $5.3K | $3.5K | $3.6K | $7.6K | $4.5K | $2.9K | · | |
| Investing Cash Flow | · | $0 | $3.0K | $-2.3K | $452.6K | $20.1K | $-1.7K | $7M | $4M | $22M | · | |
| Net Debt Issued | · | · | · | · | $-244.7K | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | $9M | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $9M | · | · | · | · | · | |
| Financing Cash Flow | $39M | $100M | $14M | $8M | $10M | $11M | $96.5K | $9M | $0 | $0 | · | |
| Net Change in Cash | · | · | · | · | · | $1M | $-7M | $11M | $-8M | $6M | · | |
| Free Cash Flow | · | · | · | $-12M | $-11M | $-9M | $-8M | $-6M | $-12M | $-16M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | 3448708.2% | · | · | · | · | · | · | |
| Net Margin | · | · | · | · | -3421955.5% | · | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | 3448708.2% | · | · | · | · | · | · | |
| ROA | -52.4% | -32.5% | 102.2% | -235.1% | -505.0% | -148.9% | -85.2% | -121.8% | -53.2% | -91.2% | · | |
| ROE | -52.5% | -18.6% | 79.5% | -405.7% | -565.6% | -163.8% | -135.5% | -169.4% | -67.9% | -113.3% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.6 | 20.6 | 3.3 | 1.7 | 3.6 | 3.2 | 2.4 | 8.5 | 8.0 | 2.2 | · | |
| Quick Ratio | 13.6 | 20.2 | · | 1.1 | 3.6 | 3.2 | 2.1 | 8.2 | 7.7 | 2.2 | · | |
| Debt / Equity | · | 0.0 | 0.1 | 0.4 | 0.0 | 0.0 | · | · | · | · | · | |
| Interest Coverage | · | -847.6 | 343.6 | -2487.7 | · | -6065.1 | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | 0.0 | · | · | · | · | 0.0 | · | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | 0.0 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $10.42 | $26.89 | $27.15 | $0.65 | $0.17 | $0.37 | $0.56 | $3.10 | $6.29 | $0.61 | · | |
| Revenue / Share | $0.00 | $0.00 | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.91 | $-0.97 | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $10.48 | $27.74 | · | $0.93 | $0.22 | $0.50 | $0.73 | $3.26 | $1.14 | $0.36 | · | |
| EPS (TTM) | $-1.34 | $-1.15 | $-31.04 | $-0.76 | $-0.76 | $-0.76 | $-0.76 | $-0.76 | $-0.76 | $-0.76 | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $41.9K | $41.9K | $41.9K | $41.9K | $41.9K | $41.9K | $41.9K | $0 | · | |
| Net Income TTM | $-53M | $-18M | $-8M | $11M | $-32M | $-10M | $-8M | $-14M | $-9M | $-44M | · | |
| Market Cap | $114M | $21M | $7M | $407M | $41.94B | $37.56B | $15.21B | $7.34B | $22.14B | $1.75T | · | |
| Enterprise Value | · | $-74M | · | $406M | $41.94B | $37.55B | · | · | · | · | · | |
| P/E | -9.1 | -5.4 | -0.7 | -233.7 | -2189.5 | -3915.8 | -2968.4 | -2547.4 | -20631.6 | -82105.3 | · | |
| P/S | · | · | 156.8 | 9722.6 | 1001918.2 | 897077.3 | 363310.6 | 175372.5 | 528799.2 | · | · | |
| P/B | 1.2 | 0.2 | 0.8 | 272.7 | 9881.6 | 8119.1 | 4031.7 | 623.7 | 2492.5 | 102368.3 | · | |
| P / Tangible Book | 1.2 | 0.2 | 0.8 | 272.6 | 9881.6 | 8119.1 | · | · | · | · | · | |
| P / Cash Flow | -3.2 | -1.4 | -1.1 | -33.9 | -3863.6 | -4050.0 | -2012.9 | -1335.0 | -1823.5 | -110557.4 | · | |
| P / FCF | · | · | · | -33.9 | -3861.8 | -4048.5 | -2011.9 | -1333.2 | -1822.8 | -110537.3 | · | |
| EV / EBITDA | · | 3.8 | · | -36.7 | 1281.4 | -3805.1 | · | · | · | · | · | |
| EV / FCF | · | · | · | -33.8 | -3861.2 | -4047.8 | · | · | · | · | · | |
| EV / Revenue | · | · | · | 9686.7 | 1001784.9 | 896919.8 | · | · | · | · | · | |
| Earnings Yield | -11.0% | -18.6% | -141.1% | -0.43% | -0.05% | -0.03% | -0.03% | -0.04% | 0.00% | 0.00% | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $13M | $12M | $11M | $10M | $6M | $6M | $5M | $3M | $2M | $3M | $2M | $1M | $197.9K | $265.7K | $1M | $2M | |
| SG&A Expense | $6M | $5M | $6M | $6M | $6M | $6M | $3M | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Operating Expenses | $19M | $17M | $16M | $17M | $12M | $11M | $7M | $5M | $4M | $4M | $3M | $2M | $1M | $2M | $3M | $3M | |
| Operating Income | $-19M | $-17M | $-16M | $-17M | $-12M | $-11M | $-7M | $-5M | $-4M | $-4M | $-10M | $2M | $1M | $-2M | $3M | $3M | |
| Interest Expense | · | · | · | · | · | · | $-1.0K | $7.0K | $9.0K | $8.0K | $2.2K | $5.3K | $9.1K | $7.3K | $0 | $372 | |
| Other Non-op | $0 | $-4.0K | $-9.0K | $-15.0K | $-9.0K | $0 | $117.4K | $0 | $1.0K | $-117.4K | $202.1K | $0 | $911 | $-140.1K | $-7.1K | $-1.3K | |
| Net Income | $-18M | $-16M | $-16M | $-16M | $-11M | $-10M | $-6M | $-4M | $-4M | $-4M | $-7M | $2M | $-1M | $-1M | $14M | $3M | |
| EPS (Basic) | $-0.35 | $-0.35 | $-0.39 | $-0.40 | $-0.27 | $-0.28 | $3.99 | $-0.19 | $-1.83 | $-3.12 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.35 | $-0.35 | $-0.39 | $-0.40 | $-0.27 | $-0.28 | $3.99 | $-0.19 | $-1.83 | $-3.12 | · | · | · | · | · | · | |
| Shares (Basic) | 50,869,259 | 45,226,328 | · | 39,741,404 | 39,572,177 | 36,584,920 | · | 21,161,143 | 1,958,245 | 1,219,139 | · | · | · | · | · | · | |
| Shares (Diluted) | 50,869,259 | 45,226,328 | · | 39,741,404 | 39,572,177 | 36,584,920 | · | 21,161,143 | 1,958,245 | 1,219,139 | · | · | · | · | · | · | |
| EBITDA | $-19M | $-17M | · | $-17M | $-12M | $-11M | · | $5M | $4M | $-4M | · | $2M | $1M | $2M | · | $3M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $118M | $119M | $98M | $99M | $106M | $111M | $95M | · | · | · | $10M | $345.0K | $13M | $14M | · | $4M | |
| Prepaid Expense | $3M | $4M | $6M | $3M | $395.0K | $524.0K | $2M | $1M | $1M | $2M | $2M | $474.9K | $362.6K | $545.4K | $738.9K | $707.2K | |
| Other Current Assets | $272.0K | $107.0K | $1M | · | · | $88.0K | $64.0K | $33.9K | $50.2K | $66.6K | $252.0K | $267.1K | $282.6K | $304.6K | $345.9K | · | |
| Current Assets | $122M | $123M | $104M | $103M | $106M | $112M | $97M | $100M | $11M | $14M | $12M | $12M | $14M | $15M | $3M | $5M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $4.7K | $5.7K | $5.6K | $7.2K | $9.6K | |
| Other Non-current Assets | · | · | · | · | · | · | · | $1.1K | $1.1K | $1.1K | $1.0K | $1.1K | $1.1K | $1.1K | $9.6K | $8.4K | |
| Total Assets | $122M | $123M | $104M | $103M | $106M | $112M | $97M | $100M | $11M | $14M | $12M | $12M | $14M | $15M | $3M | $5M | |
| Accounts Payable | $7M | $6M | $6M | $6M | $562.0K | $2M | $3M | $2M | $869.7K | $1M | $2M | $134.8K | $206.5K | $172.0K | $448.4K | $265.4K | |
| Accrued Liabilities | $1M | $2M | $1M | $991.0K | $2M | $929.0K | $2M | $977.5K | $592.4K | $536.4K | $1M | $293.0K | $271.6K | $307.9K | $775.0K | $424.4K | |
| Short-term Debt | · | · | · | · | · | · | · | $0 | $278.8K | $413.2K | $501.0K | $174.5K | $345.7K | $513.9K | $624.3K | $46.1K | |
| Current Liabilities | $8M | $8M | $7M | $7M | $3M | $3M | $5M | $3M | $2M | $2M | $4M | $602.2K | $823.8K | $983.9K | $2M | $689.8K | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $64.2K | $95.3K | |
| Total Liabilities | $8M | $8M | $7M | $7M | $3M | $3M | $5M | $3M | $2M | $2M | $4M | $602.2K | $823.8K | $989.3K | $2M | $785.2K | |
| Total Debt | · | · | · | · | · | · | · | $0 | $278.8K | $413.2K | · | $174.5K | $345.7K | $513.9K | · | $46.1K | |
| Common Stock | $3.0K | $2.0K | $1.0K | $1.0K | $0 | $0 | $0 | $341 | $196 | $0 | $0 | $2.4K | $2.4K | $2.2K | $3 | $3.0K | |
| Paid-in Capital | $515M | $498M | $465M | $448M | $439M | $435M | $407M | $406M | $314M | $313M | $305M | $305M | $305M | $305M | $291M | $291M | |
| Retained Earnings | $-401M | $-383M | $-367M | $-352M | $-336M | $-325M | $-315M | $-309M | $-305M | $-301M | $-297M | $-294M | $-292M | $-291M | $-290M | $-287M | |
| Stockholders' Equity | $114M | $115M | $97M | $96M | $103M | $109M | $92M | $97M | $9M | $12M | $8M | $11M | $13M | $14M | $1M | $4M | |
| Liabilities + Equity | $122M | $123M | $104M | $103M | $106M | $112M | $97M | $100M | $11M | $14M | $12M | $12M | $14M | $15M | $3M | $5M | |
| Shares Outstanding | 31,949,785 | 24,275,500 | 9,314,130 | 5,907,233 | 4,148,495 | 3,970,385 | 3,420,906 | 3,408,906 | 1,958,245 | 1,958,245 | 298,281 | 23,862,434 | 23,862,434 | 21,777,434 | 28,648 | 29,980,183 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $0 | $0 | $0 | $5.1K | $969 | $1.0K | $895 | $1.3K | $1.2K | |
| Stock-based Comp | $3M | $3M | $5M | $6M | $5M | $4M | $970.0K | $14.0K | $22.0K | $119.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-14M | $-9M | $-13M | $-9M | $-6M | $-7M | $-4M | $-3M | $-3M | $-5M | $-1M | $-2M | $-923.0K | $-2M | $-2M | $-3M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | $1.6K | $1.2K | · | $0 | |
| Investing Cash Flow | · | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $157 | $0 | $1.6K | $1.2K | $4.0K | $0 | |
| Financing Cash Flow | $13M | $30M | $12M | $3M | $278.0K | $24M | $67.0K | $92M | $-133.9K | $8M | $-174.6K | $-171.3K | $-99.9K | $14M | $2.1K | $-91.9K | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 784271.0% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 784015.3% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 784271.0% | |
| ROA | -15.7% | -13.4% | · | -15.6% | -18.6% | -16.4% | · | 7.1% | 29.0% | 25.6% | · | 23.7% | -9.9% | 14.8% | · | 42.7% | |
| ROE | -16.4% | -14.0% | · | -16.3% | -19.3% | -17.1% | · | 7.3% | 32.4% | 28.4% | · | 25.9% | -11.1% | 17.7% | · | 52.1% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 15.1 | 14.5 | · | 15.6 | 41.9 | 40.5 | · | 39.0 | 6.1 | 7.1 | · | 19.7 | 17.0 | 15.5 | · | 6.5 | |
| Quick Ratio | 14.6 | 14.0 | · | 15.1 | 41.7 | 40.2 | · | · | · | · | · | 0.6 | 16.3 | 14.7 | · | 5.5 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | 731.8 | 399.6 | -490.8 | · | 396.7 | 135.5 | 209.5 | · | 7842.7 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | · | · | 0.0 | · | · | · | · | · | · | · | · | · | 0.0 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.56 | $4.72 | · | $16.29 | $24.91 | $27.53 | · | $28.52 | $4.53 | $6.35 | · | $0.47 | $0.55 | $0.66 | · | $0.13 | |
| Revenue / Share | · | $0.00 | · | · | · | $0.00 | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.21 | · | · | · | $-0.19 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $3.69 | $4.89 | · | $16.83 | $25.43 | $28.06 | · | · | · | · | · | $0.01 | $0.56 | $0.66 | · | $0.13 | |
| EPS (TTM) | $-1.49 | $-1.41 | · | $3.04 | $3.25 | $1.69 | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | · | · | · | · | $49.3K | $49.3K | $49.3K | · | $49.3K | $49.3K | $49.3K | · | $49.3K | |
| Net Income TTM | $-65M | $-58M | · | $-43M | $-31M | $-24M | · | $-19M | $-13M | $-10M | · | $13M | $14M | $12M | · | $-13M | |
| Market Cap | $465M | $388M | · | $45M | $24M | $26M | · | $12M | $6M | $8M | · | $571M | $573M | $810M | · | $8.15B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $571M | $560M | $796M | · | $8.15B | |
| P/E | -9.8 | -11.3 | · | 2.5 | 1.8 | 3.9 | · | · | · | · | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | 239.3 | 119.8 | 168.5 | · | 11581.2 | 11619.9 | 16437.1 | · | 165454.9 | |
| P/B | 4.1 | 3.4 | · | 0.5 | 0.2 | 0.2 | · | 0.1 | 0.7 | 0.7 | · | 50.6 | 43.3 | 56.7 | · | 2062.4 | |
| P / Tangible Book | 4.1 | 3.4 | · | 0.5 | 0.2 | 0.2 | · | 0.1 | 0.7 | 0.7 | · | 50.6 | 43.3 | 56.7 | · | 2062.4 | |
| P / Cash Flow | · | -41.7 | · | · | · | -3.7 | · | · | · | · | · | · | · | -469.7 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 11577.7 | 11355.2 | 16155.1 | · | 165378.6 | |
| Earnings Yield | -10.2% | -8.8% | · | 40.0% | 56.4% | 25.8% | · | · | · | · | · | · | · | · | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $0 | $0 | · | · | · |
| Faaliyet Kâr Marjı % | · | · | · | · | 3448708.2% |
| Net Gelir | $-53M | $-18M | $-8M | $11M | $-32M |
| Seyreltilmiş Hisse Başı Kâr | $-1.34 | $-1.15 | $-31.04 | · | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | 0.0 | 0.1 | 0.4 | 0.0 |
| Cari Oran | 14.6 | 20.6 | 3.3 | 1.7 | 3.6 |
| Cari Oran | 13.6 | 20.2 | · | 1.1 | 3.6 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | · | · | · | $-12M | $-11M |
Kurumsal Sahipler (13F) 130 dosya · $493.7M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
130
Tutulan Değer
$493.7M
Yeni pozisyonlar
59
Çıkan pozisyonlar
9
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 59 (+24 önceki Ç'ye göre) | 9 (+9 önceki Ç'ye göre) | 42 (+16 önceki Ç'ye göre) | 13 (+8 önceki Ç'ye göre) | +11.2M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| FMR LLC | $57.361.528 | 3.942.373 | 11,62% | Hisse senetleri |
| Vivo Capital, LLC | $36.375.000 | 2.500.000 | 7,37% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $29.065.739 | 1.815.474 | 5,89% | Hisse senetleri |
| BlackRock, Inc. | $25.142.226 | 1.727.988 | 5,09% | Hisse senetleri |
| PERCEPTIVE ADVISORS LLC | $24.735.000 | 1.700.000 | 5,01% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $16.690.611 | 1.147.121 | 3,38% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $12.749.146 | 876.230 | 2,58% | Hisse senetleri |
| Ikarian Capital, LLC | $11.459.580 | 787.600 | 2,32% | Hisse senetleri |
| Candriam S.C.A. | $10.896.012 | 749.588 | 2,21% | Hisse senetleri |
| CITADEL ADVISORS LLC | $10.600.562 | 728.561 | 2,15% | Hisse senetleri |
| RTW INVESTMENTS, LP | $10.135.094 | 696.570 | 2,05% | Hisse senetleri |
| Stonepine Capital Management, LLC | $9.603.000 | 660.000 | 1,95% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $9.308.074 | 639.537 | 1,89% | Hisse senetleri |
| MARSHALL WACE, LLP | $8.520.160 | 585.578 | 1,73% | Hisse senetleri |
| BRAIDWELL LP | $8.503.195 | 584.412 | 1,72% | Hisse senetleri |
| Point72 Asset Management, L.P. | $8.100.873 | 556.761 | 1,64% | Hisse senetleri |
| Velan Capital Investment Management LP | $8.002.282 | 549.985 | 1,62% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $7.858.833 | 540.126 | 1,59% | Hisse senetleri |
| Woodline Partners LP | $7.729.746 | 531.254 | 1,57% | Hisse senetleri |
| STATE STREET CORP | $7.432.344 | 510.814 | 1,51% | Hisse senetleri |
| Sofinnova Investments, Inc. | $7.275.567 | 500.039 | 1,47% | Hisse senetleri |
| MORGAN STANLEY | $6.288.801 | 432.220 | 1,27% | Hisse senetleri |
| Qube Research & Technologies Ltd | $6.254.943 | 429.893 | 1,27% | Hisse senetleri |
| Siren, L.L.C. | $6.214.902 | 427.141 | 1,26% | Hisse senetleri |
| Caption Management, LLC | $5.815.635 | 399.700 | 1,18% | Alım opsiyonu |
| Ikarian Capital, LLC | $5.428.605 | 373.100 | 1,10% | Alım opsiyonu |
| TWO SIGMA INVESTMENTS, LP | $5.141.825 | 353.390 | 1,04% | Hisse senetleri |
| BVF INC/IL | $4.940.438 | 339.549 | 1,00% | Hisse senetleri |
| Bank of New York Mellon Corp | $4.733.067 | 325.296 | 0,96% | Hisse senetleri |
| Trexquant Investment LP | $4.679.338 | 321.604 | 0,95% | Hisse senetleri |
| BOOTHBAY FUND MANAGEMENT, LLC | $4.526.316 | 311.087 | 0,92% | Hisse senetleri |
| DIADEMA PARTNERS LP | $4.466.850 | 307.000 | 0,90% | Alım opsiyonu |
| Logos Global Management LP | $4.365.000 | 300.000 | 0,88% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.207.336 | 289.164 | 0,85% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $4.000.464 | 274.946 | 0,81% | Hisse senetleri |
| JANE STREET GROUP, LLC | $3.879.845 | 266.656 | 0,79% | Hisse senetleri |
| Avidity Partners Management LP | $3.869.340 | 265.934 | 0,78% | Hisse senetleri |
| Caption Management, LLC | $3.710.250 | 255.000 | 0,75% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $3.686.196 | 253.518 | 0,75% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.422.160 | 235.200 | 0,69% | Satım opsiyonu |
| ADAR1 Capital Management, LLC | $3.207.722 | 220.462 | 0,65% | Hisse senetleri |
| VANGUARD GROUP INC | $3.116.545 | 255.664 | 0,63% | Hisse senetleri |
| NORTHERN TRUST CORP | $2.897.400 | 199.134 | 0,59% | Hisse senetleri |
| Balyasny Asset Management L.P. | $2.822.700 | 194.000 | 0,57% | Alım opsiyonu |
| ExodusPoint Capital Management, LP | $2.684.490 | 184.501 | 0,54% | Hisse senetleri |
| Ensign Peak Advisors, Inc | $2.573.735 | 176.889 | 0,52% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.456.637 | 168.841 | 0,50% | Hisse senetleri |
| Integral Health Asset Management, LLC | $2.429.850 | 167.000 | 0,49% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $2.386.200 | 164.000 | 0,48% | Hisse senetleri |
| Nuveen, LLC | $2.345.271 | 161.187 | 0,48% | Hisse senetleri |
Aktivistler ve %5+ sahipler 5 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Christopher Thomas Giordano ×2 başvurular | 31 Temmuz 2026 | 4,32% | Değişiklik | · | SEC |
| Declan Doogan ×5 başvurular | 09 Şubat 2023 | · | İlk başvuru | Pasif yatırım | SEC |
| Stuart Rich, Andrea Rich 2021 Irrevocable Trust, Stuart Rich 2022 Irrevocable Trust ×5 başvurular | 09 Şubat 2023 | · | İlk başvuru | Pasif yatırım | SEC |
| Armistice Capital, LLC, Steven Boyd ×4 başvurular | 17 Haziran 2022 | · | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| Ziyad Binsalamah ×2 başvurular | 02 Haziran 2020 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 19 içeriden öğrenenler · 8 yöneticiler · 13 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Christopher Thomas Giordano | CEO | 15 Eylül 2026 P | 22.174 | 5 | 0 | $40.100 |
| Anthony A Ditonno | CEO | 06 Temmuz 2021 A | · | 0 | 0 | $0 |
| Christian J Stern | Chief Executive Officer | 10 Ağustos 2011 F | 147.607 | 0 | 0 | $0 |
| Thomas R Staab II | Chief Financial Officer | 11 Eylül 2026 P | 15.675 | 1 | 0 | $11.010 |
| Thomas Mcgauley | Interim CFO | 30 Ocak 2026 M | 5.000 | 3 | 0 | $58.180 |
| Michael B Jebsen | CFO | 05 Ocak 2021 A | 34.680 | 0 | 0 | $0 |
| Stuart Rich | Chief Medical Officer | 09 Ocak 2026 A | 5.266 | 5 | 0 | $96.430 |
| Gerald L Klein | Chief Medical Officer | 14 Ekim 2011 F | 13.542 | 0 | 0 | $0 |
| Declan Doogan | Yönetim kurulu üyesi | 16 Eylül 2026 P | 55.274 | 1 | 0 | $101.760 |
| Robyn Hunter | Yönetim kurulu üyesi | 09 Ocak 2026 A | · | 0 | 0 | $0 |
| Michael H. Davidson | Yönetim kurulu üyesi | 09 Ocak 2026 A | 2.881 | 0 | 0 | $0 |
| June Sherie Almenoff | Yönetim kurulu üyesi | 09 Ocak 2026 A | 1.993 | 4 | 0 | $29.906 |
| James P. Mitchum | Yönetim kurulu üyesi | 10 Haziran 2021 A | 26.000 | 0 | 0 | $0 |
| Ronald R Blanck | Yönetim kurulu üyesi | 18 Mayıs 2020 P | 6.062 | 0 | 0 | $0 |
| Chris A Rallis | Yönetim kurulu üyesi | 01 Mayıs 2019 A | 14.490 | 0 | 0 | $0 |
| William A. Chatfield | Yönetim kurulu üyesi | 01 Mayıs 2012 A | 42.289 | 0 | 0 | $0 |
| Richard M Kiral | Yönetim kurulu üyesi | 01 Mart 2011 A | 6.951 | 0 | 0 | $0 |
| PROEHL GERALD T | · | 09 Ocak 2026 A | 1.667 | 0 | 0 | $0 |
| John P Kelley | · | 15 Mart 2017 F | 1.282.932 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 14 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 21.886 SH | 19 Ağustos 2026 | Günlük |
| IWC · iShares Trust | 0,01% | 85.058 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,01% | 11.967 NS | 31 Temmuz 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 144.811 SH | 19 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,01% | 68.684 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 642.583 SH | 11 Eylül 2026 | Günlük |
| DCOR · Dimensional ETF Trust | 0,00% | 2.603 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 27.926 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 5.403 NS | 31 Temmuz 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 3.160 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 277.850 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 852.259 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.144 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 238.184 SH | 11 Eylül 2026 | Günlük |
TENX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 16 analist
AL
Medyan hedef
$5.00
+152,5%
3 18,8%
Güçlü Al
8 50,0%
Al
5 31,2%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
9 analist · 2026-10-04Ortalama hedef $12.56 +534,1%
← Tüm hedeflerin altında
Mevcut fiyat $1.98
Düşük$4.00
Ortalama$12.56
Yüksek$36.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| TENX | $114M | -9.1 | · | · | -52.5% | · |
| SERA | · | -4.4 | 5.2% | -39417.3% | -39.0% | · |
| GANX | $135M | -5.3 | -60.6% | · | -181.1% | · |
| RNXT | · | -2.6 | 2511.6% | · | · | · |
| ALDX | $312M | -9.2 | · | · | -68.0% | · |
| GRML | · | · | · | · | -104.9% | · |
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | · |
| RNTX | · | -0.6 | · | · | · | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Tem 31, 2026